AlphaBeta Pharma is a group of companies involved in the research and development of novel affordable remedies and safe medical devices and diagnostics to improve patients’ life, and it partners with other individuals, companies and governments to maintain a steadily growing pipeline covering a wide spectrum of maladies in such therapeutic areas as orphan indications, pain/inflammation, and anti-infectives.

AlphaBeta Pharma develops innovative solutions from public, governmental and private sources worldwide converting theories into patented, licensed products. It does invest in building intellectual property protection, and develop devices through proof-of-concept and prototype stage and license onwards to the markets. They also distribute and market products internationally and have regular contact with a very wide range of healthcare customers, regulatory bodies and development partners.

AlphaBeta Pharma Group headquarters is in London, United Kingdom, beside a Clinical Research office and a depot warehouse in Istanbul, Turkey and a recent acquisition of a 12-bed phase II unit in Cairo, Egypt, AlphaBeta Pharma has incorporated a new company in Dubai, UEA for Marketing, Sales & Distribution. The Company has achieved a double figure growth in the year 2010-2011 with a healthy business projection for the 2012.

Nature is the world’s foremost international weekly scientific journal and is the flagship journal for Nature Publishing Group (NPG). Nature publishes the finest peer-reviewed research in all fields of science and technology, and provides timely, hard-hitting, insightful and arresting news and interpretation to all readers who require the best possible perspective of the evolving scientific world. Visit www.nature.com/nature

NPG also publishes other journals, online databases, and services across the life, physical, chemical and applied sciences and clinical medicine – such as Nature Middle East.

Nature Middle East is a free portal for scientific and medical research in the region. Nature Middle East includes highlights, news and features, an interactive blog, job vacancies and local events. Visit www.nature.com/nmiddleeast

Found Animals Foundation presents The Michelson Prize & Grants in Reproductive Biology- The $25 million Michelson Prize will be offered to the first entity to provide the foundation with a safe and effective non-surgical sterilant for male and female cats and dogs. Michelson Grants of up to $250,000 per year per grant are available to fund research in pursuit of this goal. Visit http://michelson.foundanimals.org/ for more information.

Silicon Valley-based SRI International, a nonprofit research and development organization, performs sponsored R&D for governments, businesses, and foundations. SRI brings its innovations to the market- place through technology licensing, new products, and spin-off ventures. SRI is known for world-changing innovations in computing, health and pharmaceuticals, chemistry and materials, sensing, energy, education, national defense, and more.

Global Information, Inc. (GII) is an information service company with offices in 6 countries and have sales agency contracts with over 250 international research companies. We sell 30,000 market research reports published by these publishers and accept customised research projects.

With offices in Japan, Korea, Singapore, Taiwan, Brussels, and the United States, we have expanded our client base and provide continuous 24 hour service. GII's experience and proactive marketing philosophy have allowed us to develop key relationships with suppliers hence provide our clients with the highest quality business intelligence available. Visit us at http://www.giiresearch.com/ for more information.

MDPI.com (where MDPI stands for Multidisciplinary Digital Publishing Institute) is a platform for peer-reviewed, scientific open access journals which is operated by MDPI AG, based in Basel, Switzerland. MDPI publishes over 60 diverse electronic, open access journals, including Molecules (launched in 1996; Impact Factor 1.988), the International Journal of Molecular Sciences (launched in 2000; Impact Factor 2.279), Sensors (launched in 2001; Impact Factor 1.771) and Marine Drugs (launched in 2003; Impact Factor 3.471). Our publishing activities are supported by more than 3,000 active scientists on our journals' international editorial boards including several Nobelists. More than 35,000 unique authors already published with MDPI, and 70,000 scholars are in the pool of reviewers. MDPI.com counts more than 2,300,000 webpage views monthly.

Technology Networks has been established for over 10 years and is now the leading provider of free information services for life science professionals. This includes news, events, posters, videos, webcasts, application notes, new products, a literature search engine and product directories. The information is specifically tailored to over 30 individual communities with specific interests, all of which can be accessed through TechnologyNetworks.com.

Indian Journal of Novel Drug Delivery (ISSN 0975-5500) is an official publication of Karnataka Education and Scientific Society, Hubli, INDIA. The IJNDD is an International indexed peer-reviewed, quarterly, open access, print and online journal, publishes innovative papers, reviews, mini-reviews, rapid communications and notes dealing with physical, chemical, biological, microbiological and engineering studies related to the conception, design, production, characterization and evaluation of drug delivery systems in vitro and in vivo with strong emphasis on originality and scientific quality. IJNDD is abstracted and indexed in Ulrich's Periodicals Directory, Index Copernicus International S.A., Open J-Gate, HINARI, GFMER, Google Scholar, Old Library, New Jour, Genamics JournalSeek, Science Central, PSOAR. For more information visit us at http://www.ijndd.com

One Davis Square, Somerville, MA 02144 | T: 617.591.3300 | F: 617.591.3399 | www.naturalstandard.com

---

Natural Standard is an international research collaboration that provides high-quality, evidence-based information about complementary and alternative medicine (CAM).

Using a comprehensive methodology and reproducible grading scales, Natural Standard generates evidence-based, consensus-based systematic reviews that are peer-reviewed by a multidisciplinary Editorial Board. Our mission is to provide objective, reliable information that helps clinicians, patients, and healthcare institutions make more informed and safer therapeutic decisions.